Tomoyuki Makino

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Locally Advanced

Transforming Growth Factor

Radical Prostatectomy

Top Venues

International journal of urology : official journal of the Japanese Urological Association

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroshi Kano, Yoshifumi Kadono, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy. Cancers 16 (7) (2024)
Hiroshi Kano, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer. Biomedicines 12 (2) (2024)
Ryunosuke Nakagawa, Kouji Izumi, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Does radical cystectomy have a better prognosis than bladder conservative treatment in the real world? International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Ryunosuke Nakagawa, Kouji Izumi, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Does radical cystectomy have a better prognosis than bladder conservative treatment in the real world? International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Hiroshi Kano, Yoshifumi Kadono, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy. Cancers 16 (7) (2024)
Ryunosuke Nakagawa, Kouji Izumi, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Does radical cystectomy have a better prognosis than bladder conservative treatment in the real world? International journal of urology : official journal of the Japanese Urological Association (2024)
Hiroshi Kano, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer. Biomedicines 12 (2) (2024)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Atsushi Mizokami
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (6) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Atsushi Mizokami
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (6) (2023)
Tomoyuki Makino, Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
Epidemiology and Prevention of Renal Cell Carcinoma. Cancers 14 (16) (2022)
Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer. Biomedicines 10 (10) (2022)
Hiroaki Iwamoto, Kouji Izumi, Tomoyuki Makino, Atsushi Mizokami
Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer. Cancers 14 (7) (2022)
Ryunosuke Nakagawa, Hiroaki Iwamoto, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Norihito Akatani, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono, Atsushi Takamatsu, Kotaro Yoshida, Atsushi Mizokami
Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men. Cancers 14 (19) (2022)
Tomoyuki Makino, Kouji Izumi, Atsushi Mizokami
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment. Biomedicines 9 (4) (2021)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Atsushi Mizokami
Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer. Cancers 13 (17) (2021)
Renato Naito, Hiroshi Kano, Takashi Shimada, Tomoyuki Makino, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Kouji Izumi, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Masuo Goto, Kyoko Nakagawa-Goto, Atsushi Mizokami
A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells. The Prostate 81 (5) (2021)
Hiroaki Iwamoto, Kouji Izumi, Takashi Shimada, Hiroshi Kano, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer. The Prostate 81 (1) (2020)
Suguru Kadomoto, Kouji Izumi, Kaoru Hiratsuka, Taito Nakano, Renato Naito, Tomoyuki Makino, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Kyoko Nakagawa Goto, Atsushi Mizokami
Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis. Cancers 12 (1) (2019)